Martin B. Brenner
2024
In 2024, Martin B. Brenner earned a total compensation of $1.3M as Chief Executive Officer and Chief Scientific Officer at iBio, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,946 |
|---|---|
| Option Awards | $518,286 |
| Salary | $522,365 |
| Other | $21,689 |
| Total | $1,271,286 |
Brenner received $522.4K in salary, accounting for 41% of the total pay in 2024.
Brenner also received $208.9K in non-equity incentive plan, $518.3K in option awards and $21.7K in other compensation.
Rankings
In 2024, Martin B. Brenner's compensation ranked 44th out of 207 executives tracked by ExecPay. In other words, Brenner earned more than 78.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 44 out of 207 | 79th |
Division Manufacturing | 13 out of 89 | 85th |
Major group Chemicals And Allied Products | 5 out of 36 | 86th |
Industry group Drugs | 5 out of 33 | 85th |
Industry Pharmaceutical Preparations | 4 out of 30 | 87th |
Source: SEC filing on October 10, 2024.
Brenner's colleagues
We found one more compensation record of an executive working with Martin B. Brenner at iBio in 2024.
2024
Felipe Duran
iBio